Back to Search
Start Over
Thiotepa intrathecal injections for myelomatous central nervous system involvement.
- Source :
-
British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (2), pp. e9-e12. Date of Electronic Publication: 2021 Mar 09. - Publication Year :
- 2021
- Subjects :
- Aged
Antineoplastic Agents, Alkylating therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Central Nervous System pathology
Female
Humans
Incidence
Injections, Spinal
Male
Meningeal Neoplasms drug therapy
Meningeal Neoplasms pathology
Methylprednisolone administration & dosage
Methylprednisolone therapeutic use
Middle Aged
Multiple Myeloma epidemiology
Neuroprotective Agents administration & dosage
Neuroprotective Agents therapeutic use
Plasmacytoma cerebrospinal fluid
Plasmacytoma diagnosis
Safety
Thiotepa therapeutic use
Treatment Outcome
Antineoplastic Agents, Alkylating administration & dosage
Central Nervous System drug effects
Multiple Myeloma complications
Multiple Myeloma drug therapy
Plasmacytoma drug therapy
Thiotepa administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 193
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33686665
- Full Text :
- https://doi.org/10.1111/bjh.17343